LASA — Lasa Supergenerics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for Lasa Supergenerics, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	R2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	60.6	44	172	23.9	15
Net Total Accounts Receivable
Net Total Receivables	207	148	210	70.5	71.9
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	759	643	663	392	379
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1,460	1,375	1,251	928	863
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	2,320	2,079	2,092	1,639	1,509
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	759	405	447	427	489
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	905	489	513	456	542
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	1,415	1,589	1,579	1,183	967
Total Liabilities & Shareholders' Equity	2,320	2,079	2,092	1,639	1,509
Total Common Shares Outstanding